Search Result "TRAIL-R1"
Targeting Cell Death and Survival Receptors in Hepatocellular Carcinoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 6 Year: 2011 Page: 576-584
Author(s): Jordi Muntane
A Combined Approach with Rituximab Plus Anti-TRAIL-R Agonistic Antibodies for the Treatment of Haematological Malignancies
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2085-2099
Author(s): Silvia Sancilio, Vittorio Grill, Roberta Di Pietro
Death Receptor Activation-Induced Hepatocyte Apoptosis and Liver Injury
Journal: Current Molecular Medicine
Volume: 3 Issue: 6 Year: 2003 Page: 491-508
Author(s): Xiao-Ming Yin, Wen-Xing Ding
TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2013 Page: 2254-2271
Author(s): C. Gasparini, L. Vecchi Brumatti, L. Monasta, G. Zauli
TNF-Related Apoptosis-Inducing Ligand (TRAIL): A Potential Candidate for Combined Treatment of Hematological Malignancies
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 2 Year: 2004 Page: 3673-3681
Author(s): Paola Secchiero, Mauro Vaccarezza, Arianna Gonelli, Giorgio Zauli
Death Receptors as Targets of Cancer Therapeutics
Journal: Current Cancer Drug Targets
Volume: 4 Issue: 1 Year: 2004 Page: 97-104
Author(s): M. Saeed Sheikh, Ying Huang
Bleomycin Induced Sensitivity to TRAIL/Apo-2L-Mediated Apoptosis in Human Seminomatous Testicular Cancer Cells is Correlated with Upregulation of Death Receptors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2015 Page: 99-106
Author(s): Mujgan Timur,Aysegul Cort,Evrim Ozdemir,Sureyya Bilmen Sarikcioglu,Salih Sanlioglu,Ahter Dilsad Sanlioglu,Tomris Ozben
Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with TrichostatinA and Zebularine
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 7 Year: 2023 Page: 817-831
Author(s):
TRAIL Receptor-Induced Cell Death Regulation: An Update to Our Deadly Discussion
Ebook: Topics in Anti-Cancer Research
Volume: 3 Year: 2014
Author(s): Olivier Micheau,Sarah Shirley,Alexandre Morizot
Doi: 10.2174/9781608059089114030004
Cell Cycle Dysregulation During Hiv Infection: Perspectives of a Target Based Therapy
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 2 Issue: 1 Year: 2002 Page: 53-62
Author(s): Domenico Galati, Marialuisa Bocchino, Mirko Paiardini, Barbara Cervasi, Guido Silvestri, Giuseppe Piedimonte